Скачать или смотреть Trump's Tariff Tango: Indian Pharma & IT - Invest or Retreat? | Parimal Ade

Is it the right time to invest in India's booming Pharma and IT sectors amidst the shadow of Trump's Tariffs? In this concise YouTube Short, Parimal Ade delves into the complex truth – it's NOT a straightforward answer!

Discover how the recently announced 100% tariffs on branded & patented pharmaceutical imports might (or might not) impact India's 'Pharmacy of the World,' which thrives on generic drug exports. We break down the nuances: from the relative safety of Indian generics to the lurking concerns of future tariff expansions and the strategic moves Indian drugmakers are making with AI adoption and market diversification.

Then, shift to the Indian IT sector. While not directly targeted by these specific pharma tariffs, we explore the indirect impacts – potential reductions in US client spending, rising operational costs due to H1B visa changes, and broader geopolitical instability. Learn why a nuanced approach is crucial for IT investors navigating these global headwinds and embracing new opportunities in AI and digital transformation.

This short provides a quick yet insightful analysis, cutting through the noise to help you understand the risks and rewards. Don't make broad assumptions – empower your investment decisions with a deeper look at company-specific exposure and long-term strategies.

Like this video if you found it helpful, subscribe for more sharp insights from Parimal Ade, and let us know your thoughts in the comments below!

Complete Fundamental Stock Analysis Tool - Stock-o-meter:
https://investyadnya.in/stock-o-meter

Research Based Ready-made Model Portfolios:
https://investyadnya.in/model-portfolios

Comprehensive Mutual Fund Reviews:
https://investyadnya.in/fund-o-meter

Yadnya Books and eBooks now available:
On Amazon - https://amzn.to/47x0RS4
On Flipkart - https://fktr.in/y3OZ3GF
On our website - https://shop.investyadnya.in

LEGAL DISCLAIMER:

Use of this information is at the user's own risk. The Company and its directors, associates and employees will not be liable for any loss or liability incurred to the user due to investments made or decisions taken based on the information provided herein. The investment discussed or views expressed herein may not be suitable for all investors. The users should rely on their own research and analysis and should consult their investment advisors to determine the merit, risks and suitability of recommendation. Past performance is not a guarantee for future performance or future results. Information herein is believed to be reliable, although its accuracy and completeness cannot be guaranteed. The images used may be copyright of the company or third party. As a condition to using the services, the user agrees to the terms of use of the website and the services.


DISCLOSURES UNDER SEBI (RESEARCH ANALYST) REGULATIONS, 2014:

Yadnya Academy Pvt. Ltd. (InvestYadnya) is registered with SEBI under SEBI (Research Analyst) Regulations, 2014 with registration no. INH000008349.
Disclosure with regard to ownership and material conflicts of interest
1. Neither Research Analyst nor the entity nor his associates or relatives have any financial interest in the subject Company;
2. Neither Research Analyst nor the entity nor its associates or relatives have actual / beneficial ownership of one per cent or more securities of the subject Company, at the end of the month immediately preceding the date of publication of the research report or date of public appearance;
3. Neither Research Analyst nor the entity nor its associates or his relatives have any other material conflict of interest at the time of publication of the research report or at the time of public appearance.
Disclosure with regard to receipt of Compensation
1. The Research Entity and its associates have not received compensation from the subject company in the past twelve months.
2. The subject company is not or was not a client during the twelve months preceding the date of recommendation.